Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Digest.
Press releases published on March 20, 2025
Creative Medical Technology Holdings Secures FDA Clearance for Expanded Dose Escalation in the Clinical Trial of CELZ-201-DDT for Chronic Lower Back Pain
GlobeNewswire
·
March 20, 2025
PHOENIX, March 20, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (the “Company”), a clinical-stage biotechnology company specializing in regenerative medicine, today announced that the U.S. Food and Drug Administration …
Alarum Technologies Announces Fourth Quarter and Annual 2024 Results
GlobeNewswire
·
March 20, 2025
A Pivotal Year, Marking Accomplishment of Strategic Shift to Data Collection, Hits Milestones Toward Becoming a Driving Force in the AI Revolution 2024 revenue increased to $31.8 million, of which $7.4 million was in the fourth quarter; 2024 net profit …
Duke Robotics Reports 2024 Financial Results and Provides Business Update
GlobeNewswire
·
March 20, 2025
FORT LAUDERDALE, FL, March 20, 2025 (GLOBE NEWSWIRE) -- Duke Robotics Corp. (OTCQB: DUKR) ("Duke Robotics" or the "Company"), a leader in advanced robotics technology and autonomous drone solutions, today reported financial results for the fourth quarter …
Revival Gold Enters Marketing Services Agreement
GlobeNewswire
·
March 20, 2025
TORONTO, March 20, 2025 (GLOBE NEWSWIRE) -- Revival Gold Inc. (TSXV: RVG, OTCQX: RVLGF) ("Revival Gold" or the "Company") is pleased to announce that the Company has entered into a marketing service agreement (the “Agreement”) with Resource Stock Digest (“ …
Nayax Introduces Innovative State-of-Charge Feature for EV Kiosk, Elevating EV Charging Experience
GlobeNewswire
·
March 20, 2025
HERZLIYA, Israel, March 20, 2025 (GLOBE NEWSWIRE) -- Nayax Ltd. (Nasdaq: NYAX; TASE: NYAX), a global commerce enablement, payments and loyalty platform designed to help merchants scale their business, today announced the launch of its State-of-Charge …
InflaRx Reports Full Year 2024 Results and Highlights Key Achievements and Expected Milestones
GlobeNewswire
·
March 20, 2025
Received European Commission approval for GOHIBIC® (vilobelimab) for the treatment of SARS-CoV-2-induced acute respiratory distress syndrome (ARDS) Achieved 30-patient recruitment milestone in Phase 3 vilobelimab trial in pyoderma gangrenosum (PG) to …
Barinthus Bio Reports Full Year 2024 Financial Results and Updates on Corporate Developments
GlobeNewswire
·
March 20, 2025
Strategic transformation ongoing, positioning the Company as a focused leader in immunology and inflammatory diseases Highly differentiated, potentially curative immunotherapy for celiac disease (VTP-1000) in the clinic, with first data expected in third …
Emerging Markets Report: Ceilings & Floors
GlobeNewswire
·
March 20, 2025
An Emerging Markets Sponsored Commentary ORLANDO, Fla., March 20, 2025 (GLOBE NEWSWIRE) -- At the Emerging Market Report we are definitively newshounds, constantly looking to see what news from a Company could further its fortunes or more rarely, what news …
Paramount Secures Approval from Oregon State Agencies for Proposed Technologies and Processes at Its Wholly Owned Grassy Mountain Gold Project
GlobeNewswire
·
March 20, 2025
WINNEMUCCA, Nevada, March 20, 2025 (GLOBE NEWSWIRE) -- Paramount Gold Nevada Corp. (NYSE American: PZG) (“Paramount” or the “Company”) announced today that, at a public meeting of the Technical Review Team (“TRT”), the state agencies voted unanimously to …
Titan Hits Upper Range of Production Guidance and Beats Cost Guidance
GlobeNewswire
·
March 20, 2025
VANCOUVER, British Columbia, March 20, 2025 (GLOBE NEWSWIRE) -- Titan Mining Corporation (TSX: TI, OTCQB: TIMCF) (“Titan” or the "Company") is pleased to announce the results for the year ended December 31, 2024. The Company has achieved the top end of its …
Intended Retirement of Independent Non-executive Directors and changes of composition of board committees
GlobeNewswire
·
March 20, 2025
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 20, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED” or the “Company”) (Nasdaq/AIM:HCM, HKEX:13) today announces that Mr Paul Rutherford Carter and Mr Graeme Allan Jack, who have both …
Pharming Group announces first patient dosed in Phase II clinical trial of leniolisib for common variable immunodeficiency (CVID) with immune dysregulation
GlobeNewswire
·
March 20, 2025
Multi-center clinical trial includes sites located in the US, UK and EU Second Phase II clinical trial studying leniolisib for additional primary immunodeficiencies (PIDs) CVID patients demonstrate clinical phenotypes similar to APDS, with global …
Paratek Pharmaceuticals to Acquire Optinose, Creating Significant Commercial Expansion Opportunities for XHANCE® in Chronic Rhinosinusitis (CRS)
GlobeNewswire
·
March 20, 2025
Paratek will accelerate access for XHANCE beyond specialists to primary care providers maximizing the recent label expansion for CRS in a ~10‑million‑patient market Acquisition advances Paratek’s vision to become a multi-product company focused on …
HUTCHMED Highlights Savolitinib SAVANNAH Phase II and Other Data at European Lung Cancer Congress 2025
GlobeNewswire
·
March 20, 2025
— SAVANNAH Phase II trial demonstrated high and durable response rates with savolitinib plus TAGRISSO® in MET-high lung cancer, representing a promising chemo-free oral treatment strategy to address mechanisms of resistance in the advanced setting — — Long …